Menu
Fechar
hrs4r
 I want to donate

The current challenges in healthcare are population aging, the increase in chronic diseases, and the need to ensure the sustainability of the healthcare system, placing patients and citizens at the center. Innovation in the field of digital health can help advance toward personalized, preventive, population-based, predictive, and participatory medicine (5P Medicine).

Our group focuses on the development, validation, and translation of valuable and impactful digital health solutions into clinical practice.

The ultimate goal is to develop, validate, and implement digital health solutions created by and for healthcare professionals, with the participation of citizens, improving health outcomes, patient and professional experiences, and facilitating cost-efficient use of resources.

Main lines of research

1- Telemonitoring

2- Big Data Analysis - Artificial Intelligence

3- Decision Support Systems

4- Process Management - Digital Solutions

5- 3D Printing - Trauma Teaching

6- Digital Solutions in Emergency-Critical Care

Publications
Dégano IR, Ramos R, García-Gil M, Zamora A, Comas-Cufí M, Francés A, Garcia-Elias A, Marrugat J

Three-year events and mortality in cardiovascular disease patients without lipid-lowering treatment

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2020, 27, 2102-2104 dx.doi.org/10.1177/2047487319862103
Ramos R, Masana L, Comas-Cufí M, García-Gil M, Martí-Lluch R, Ponjoan A, Plana N, Alves-Cabratosa L, Marrugat J, Elosua R, Dégano IR, Gomez-Marcos MA, Zamora A

Derivation and validation of SIDIAP-FHP score: A new risk model predicting cardiovascular disease in familial hypercholesterolemia phenotype

Atherosclerosis, 2020, 292, 42-51 dx.doi.org/10.1016/j.atherosclerosis.2019.10.016
Zamora A, Masana L, Plana N, Ramos R

Estimated Percentage of Patients With Stable Coronary Heart Disease Candidates for PCSK9 Inhibitors. Response

REVISTA ESPANOLA DE CARDIOLOGIA, 2019, 72, 519-520 dx.doi.org/10.1016/j.rec.2018.12.009
Zamora A, Masana L, Comas-Cufi M, Plana N, Vila À, García-Gil M, Alves-Cabratosa L, Elosua R, Marrugat J, Ramos R

Number of Patients Eligible for PCSK9 Inhibitors Based on Real-world Data From 2.5 Million Patients

REVISTA ESPANOLA DE CARDIOLOGIA, 2018, 71, 1010-1017 dx.doi.org/10.1016/j.rec.2018.03.003
Vázquez-Oliva G, Zamora A, Ramos R, Marti R, Subirana I, Grau M, Dégano IR, Marrugat J, Elosua R

Acute Myocardial Infarction Population Incidence and Mortality Rates, and 28-day Case-fatality in Older Adults, The REGICOR Study

REVISTA ESPANOLA DE CARDIOLOGIA, 2018, 71, 718-725 dx.doi.org/10.1016/j.recesp.2017.10.019
Vázquez-Oliva G, Zamora A, Ramos R, Subirana I, Grau M, Dégano IR, Muñoz D, Fitó M, Elosua R, Marrugat J

Analysis of Plasma Albumin, Vitamin D, and Apolipoproteins A and B as Predictive Coronary Risk Biomarkers in the REGICOR Study

REVISTA ESPANOLA DE CARDIOLOGIA, 2018, 71, 910-916 dx.doi.org/10.1016/j.rec.2018.01.027
Zamora A, Masana L, Comas-Cufí M, Vila À, Plana N, García-Gil M, Alves-Cabratosa L, Marrugat J, Roman I, Ramos R, XULA and ISV-Girona groups

Familial hypercholesterolemia in a European Mediterranean population-Prevalence and clinical data from 2.5 million primary care patients.

JOURNAL OF CLINICAL LIPIDOLOGY, 2017, 11, 1013-1022 dx.doi.org/10.1016/j.jacl.2017.05.012
Dégano IR, Marrugat J, Grau M, Salvador-González B, Ramos R, Zamora A, Martí R, Elosua R

The association between education and cardiovascular disease incidence is mediated by hypertension, diabetes, and body mass index.

SCIENTIFIC REPORTS, 2017, 7, 12370-12370 dx.doi.org/10.1038/s41598-017-10775-3
Competitive projects
Job offers

Team

If you are a researcher and you are interested in collaborating with any of our research groups, please fill in this form.
I am interested in
If you are a student or you want to do an internship with any of our research groups, please fill in this form.
I am interested in

About IDIBGI!

 menu